Business Description
Dipna Pharmachem Ltd
ISIN : INE0MC401013
Total Employee Number:
13Compare
Compare
Traded in other countries / regions
543594.India IPO Date
2022-09-08Description
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 3.52 | |||||
Interest Coverage | 1.61 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.84 | |||||
Beneish M-Score | 4593.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.2 | |||||
3-Year EBITDA Growth Rate | -7 | |||||
3-Year EPS without NRI Growth Rate | -19.6 | |||||
3-Year FCF Growth Rate | 23.8 | |||||
3-Year Book Growth Rate | 12.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.89 | |||||
9-Day RSI | 51.05 | |||||
14-Day RSI | 45.26 | |||||
3-1 Month Momentum % | -31.29 | |||||
6-1 Month Momentum % | -55.07 | |||||
12-1 Month Momentum % | -72.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.16 | |||||
Quick Ratio | 0.84 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 111.52 | |||||
Days Sales Outstanding | 147.22 | |||||
Days Payable | 284.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.7 | |||||
Shareholder Yield % | -134.21 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.96 | |||||
Operating Margin % | 2.99 | |||||
Net Margin % | 0.78 | |||||
EBITDA Margin % | 3.01 | |||||
FCF Margin % | -14.7 | |||||
OCF Margin % | -14.67 | |||||
ROE % | 1.83 | |||||
ROA % | 0.57 | |||||
ROIC % | 3.13 | |||||
3-Year ROIIC % | 1.67 | |||||
ROC (Joel Greenblatt) % | 11.83 | |||||
ROCE % | 5.93 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.95 | |||||
PE Ratio without NRI | 12.95 | |||||
PEG Ratio | 0.41 | |||||
PS Ratio | 0.1 | |||||
PB Ratio | 0.23 | |||||
Price-to-Tangible-Book | 0.21 | |||||
EV-to-EBIT | 6.66 | |||||
EV-to-EBITDA | 6.63 | |||||
EV-to-Revenue | 0.2 | |||||
EV-to-FCF | -1.37 | |||||
Price-to-GF-Value | 0.53 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.48 | |||||
Price-to-Graham-Number | 0.33 | |||||
| Price-to-Net-Current-Asset-Value | 1.2 | |||||
Earnings Yield (Greenblatt) % | 15.03 | |||||
FCF Yield % | -142.83 | |||||
Forward Rate of Return (Yacktman) % | -83.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dipna Pharmachem Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,249.171 | ||
| EPS (TTM) (₹) | 0.41 | ||
| Beta | 0.0602 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.41 | ||
| Volatility % | 45.09 | ||
| 14-Day RSI | 45.26 | ||
| 14-Day ATR (₹) | 0.528101 | ||
| 20-Day SMA (₹) | 4.903 | ||
| 12-1 Month Momentum % | -72.59 | ||
| 52-Week Range (₹) | 3.9 - 25 | ||
| Shares Outstanding (Mil) | 26.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dipna Pharmachem Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dipna Pharmachem Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dipna Pharmachem Ltd Frequently Asked Questions
What is Dipna Pharmachem Ltd(BOM:543594)'s stock price today?
The current price of BOM:543594 is ₹4.89. The 52 week high of BOM:543594 is ₹25.00 and 52 week low is ₹3.90.
When is next earnings date of Dipna Pharmachem Ltd(BOM:543594)?
The next earnings date of Dipna Pharmachem Ltd(BOM:543594) is .
Does Dipna Pharmachem Ltd(BOM:543594) pay dividends? If so, how much?
Dipna Pharmachem Ltd(BOM:543594) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Dipna Pharmachem Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers